Economic evaluations of pharmacist‐managed services in people with diabetes mellitus: a systematic review
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Aim: To review and evaluate the most recent literature on the economic outcomes of pharmacist‐managed services in people with diabetes. Background: The global prevalence of diabetes is increasing. Although pharmacist‐managed services have been shown to improve people's health outcomes, the economic impact of these programmes remains unclear. Methods: A systematic review was conducted of six databases. Study inclusion criteria were: (1) original research; (2) evaluation of pharmacist‐managed services in people with diabetes; (3) an economic evaluation; (4) English‐language publication; and (5) full‐text, published between January 2006 and December 2014. The quality of the full economic evaluations reviewed was evaluated using the Consolidated Health Economic Evaluation Reporting Standards checklist. Results: A total of 2204 articles were screened and 25 studies were selected. These studies were conducted in a community pharmacy (n= 10), a clinic‐ /hospital‐based outpatient facility (n= 8), or others. Pharmacist‐managed services included targeted education (n= 24), general pharmacotherapeutic monitoring (n= 21), health screening or laboratory testing services (n= 9), immunization services (n= 2) and pharmacokinetic monitoring (n= 1). Compared with usual care, pharmacist‐managed services resulted in cost savings that varied from $7 to $65,000 ($8 to $85,000 in 2014 US dollars) per person per year, and generated higher quality‐adjusted life years with lower costs. Benefit‐to‐cost ratios ranged from 1:1 to 8.5:1. Among the 25 studies reviewed, 11 were full economic evaluations of moderate quality. Conclusions: Pharmacist‐managed services had a positive return in terms of economic viability. With the expanding role of pharmacists in the healthcare sector, alongside increasing health expenditure, future economic studies of high quality are needed to investigate the cost‐effectiveness of these services.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
Diabetes Ten City Challenge: Final economic and clinical results
Fera, T., Bluml, B. M., & Ellis, W. M. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.09015 · Cited by 218
Cited by
Fazel, M. T., Bagalagel, A., Lee, J. K., Martin, J. R., & Slack, M. K. (2017) · Annals of Pharmacotherapy · doi:10.1177/1060028017711454 · Cited by 99
Murphy, M. E., Byrne, M., Galvin, R., Boland, F., Fahey, T., & Smith, S. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015135 · Cited by 94
Turner, R. M., Ma, Q., Lorig, K., Greenberg, J., & DeVries, A. R. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9225 · Cited by 39
“A systematic review of pharmacist-led diabetes education studies by Wang et al showed positive economic cost savings results in the intervention groups compared with usual care [22].”
Mechanick, J. I., Pessah-Pollack, R., Camacho, P., Correa, R., Figaro, M. K., Garber, J. R., Jasim, S., Pantalone, K. M., Trence, D., & Upala, S. (2017) · Endocrine Practice · doi:10.4158/ep171866.gl · Cited by 25
Metadata
- Authors
- Wang, Y., Yeo, Q. Q., & Ko, Y.
- Venue
- Diabetic Medicine
- Publisher
- Wiley
- Published
- 2015-10-28
- Volume
- 33
- Issue
- 4
- Pages
- 421-427
- ISSN
- 0742-3071 (ISSN-L)
- 1464-5491
- OpenAlex
- W2166366008
- Cited by
- 76
- References
- 2
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Economic evaluations of pharmacist‐managed services in people with diabetes mellitus: a systematic review. https://app.cochat.ai/papers/10.1111/dme.12976
- The paper
- Wang, Y., Yeo, Q. Q., & Ko, Y. (2016). Economic evaluations of pharmacist‐managed services in people with diabetes mellitus: a systematic review. Diabetic Medicine. https://doi.org/10.1111/dme.12976
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.